Zacks Investment Research downgraded shares of Health Insurance Innovations, Inc. (NASDAQ:HIIQ) from a buy rating to a hold rating in a report released on Wednesday.
According to Zacks, “Health Insurance Innovations, Inc. operates as a developer and administrator of web-based individual health insurance plans and ancillary products. Its product portfolio consists of short-term medical plans, accident, sickness & hospital medical plans, ancillary insurance, life insurance, lifestyle and discount services. Health Insurance Innovations, Inc. is based in Tampa, Florida. “
A number of other research analysts have also commented on HIIQ. Raymond James Financial, Inc. reissued a market perform rating on shares of Health Insurance Innovations in a report on Monday, June 26th. Canaccord Genuity reissued a buy rating and set a $30.00 price target on shares of Health Insurance Innovations in a report on Thursday, July 13th. Cantor Fitzgerald reissued an overweight rating and set a $35.00 price target (up from $30.00) on shares of Health Insurance Innovations in a report on Monday, July 17th. Craig Hallum reissued a buy rating and set a $38.00 price target (up from $28.00) on shares of Health Insurance Innovations in a report on Thursday, August 3rd. Finally, ValuEngine lowered Health Insurance Innovations from a buy rating to a hold rating in a report on Monday, August 14th. Two analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. Health Insurance Innovations has an average rating of Buy and an average target price of $31.33.
Health Insurance Innovations (NASDAQ:HIIQ) last posted its earnings results on Wednesday, August 2nd. The financial services provider reported $0.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.33 by $0.13. The company had revenue of $61.80 million for the quarter, compared to analysts’ expectations of $53.69 million. Health Insurance Innovations had a return on equity of 22.89% and a net margin of 5.56%. Health Insurance Innovations’s revenue was up 38.9% compared to the same quarter last year. On average, equities research analysts expect that Health Insurance Innovations will post $1.53 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY WARNING: This news story was first posted by Community Financial News and is the property of of Community Financial News. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The legal version of this news story can be read at https://www.com-unik.info/2017/10/12/health-insurance-innovations-inc-hiiq-downgraded-to-hold-at-zacks-investment-research.html.
In related news, insider Sheldon Wang sold 4,530 shares of Health Insurance Innovations stock in a transaction dated Thursday, September 7th. The stock was sold at an average price of $32.73, for a total transaction of $148,266.90. Following the transaction, the insider now directly owns 224,894 shares of the company’s stock, valued at $7,360,780.62. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO of HealthPocket Bruce Telkamp sold 9,970 shares of Health Insurance Innovations stock in a transaction dated Friday, September 1st. The stock was sold at an average price of $36.19, for a total value of $360,814.30. Following the transaction, the insider now directly owns 19,500 shares in the company, valued at $705,705. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 185,077 shares of company stock worth $5,357,058. 30.00% of the stock is owned by corporate insiders.
A number of large investors have recently added to or reduced their stakes in the stock. Renaissance Technologies LLC grew its holdings in Health Insurance Innovations by 68.3% during the second quarter. Renaissance Technologies LLC now owns 1,010,400 shares of the financial services provider’s stock worth $23,744,000 after acquiring an additional 410,197 shares during the period. Lyon Street Capital LLC grew its holdings in Health Insurance Innovations by 14.4% during the second quarter. Lyon Street Capital LLC now owns 627,079 shares of the financial services provider’s stock worth $14,736,000 after acquiring an additional 78,818 shares during the period. Russell Investments Group Ltd. acquired a new position in Health Insurance Innovations during the second quarter worth about $14,467,000. Capital World Investors acquired a new position in Health Insurance Innovations during the second quarter worth about $11,680,000. Finally, Emerald Mutual Fund Advisers Trust grew its holdings in Health Insurance Innovations by 12.5% during the second quarter. Emerald Mutual Fund Advisers Trust now owns 448,955 shares of the financial services provider’s stock worth $10,550,000 after acquiring an additional 50,000 shares during the period. 66.21% of the stock is currently owned by hedge funds and other institutional investors.
Health Insurance Innovations Company Profile
Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.
What are top analysts saying about Health Insurance Innovations Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Health Insurance Innovations Inc. and related companies.